查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1760528

2025年全球胜任细胞市场报告

Electrocompetent Cells Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年，胜任细胞市场规模将快速成长。至2029年，该市场规模将成长至23.1亿美元，复合年增长率为10.0%。预测期内的成长动力包括合成生物学应用的不断扩展、基于CRISPR的基因编辑需求的不断增长、个性化医疗研究的增长、转化程序自动化的兴起以及生物新兴企业投资的不断增加。预计在此期间的主要趋势包括支持CRISPR的胜任细胞、高效转化菌株、化学成分确定的生长培养基的整合、自动化细胞製备流程以及确保产品稳定性的低温运输优化包装。

日益增长的基因工程需求预计将推动胜任细胞市场的扩张。基因工程涉及有意修改生物体的 DNA，以改变其特性和功能。这种需求很大程度上是由需要透过开发产量、抗虫作物来提高农业生产力并减少对化学物质的依赖所驱动。随着基因工程成为农业、医疗保健和研究不可或缺的一部分，对高品质胜任细胞的需求也日益增长，以便有效地将外来 DNA 引入细胞。例如，美国政府机构经济研究局于 2025 年 4 月报告称，到 2024 年，美国 90% 的棉花种植面积将种植基因改造抗虫种子。

胜任细胞市场的主要企业正专注于自动化细胞处理技术等创新，这些技术支援基因工程应用的扩充性。这些自动化系统使用软体主导的通讯协定来管理细胞处理、培养、改造和储存等任务，从而提高效率、一致性和扩充性。例如，2022 年 3 月，美国生技公司赛默飞世尔科技推出了 Gibco CTS 氙气电穿孔系统。这种大容量、可客製化的电穿孔平台专为快速非病毒基因改造而设计，可实现从临床到商业规模生产的无缝过渡。它提供可程式设计条件，保持高细胞活力（高达 80%），并在无菌封闭系统中为难以转染的细胞提供有效的基因敲除（高达 90%）。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球电转化胜任细胞PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球胜任细胞市场：成长率分析
  • 全球胜任细胞市场表现：规模与成长，2019-2024
  • 全球胜任细胞市场预测：规模与成长，2024-2029，2034
  • 全球电转化胜任细胞总可定址市场（TAM）

第六章市场区隔

  • 全球胜任细胞市场（按产品类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 细菌胜任细胞
  • 酵母胜任细胞
  • 植物电转化感受态胜任细胞
  • 胜任细胞
  • 全球胜任细胞市场（按技术、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 电穿孔技术
  • 化学转换技术
  • 其他技术
  • 全球胜任细胞市场（依封装类型、效能及预测），2019-2024 年、2024-2029 年、2034 年
  • 管子
  • 盘子
  • 自订格式
  • 全球胜任细胞市场应用、效能及预测（2019-2024、2024-2029、2034）
  • 基因复製
  • 蛋白质表现
  • 转染研究
  • 基因编辑
  • 治疗应用
  • 其他用途
  • 全球胜任细胞市场（按最终用户、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 製药和生物技术公司
  • 学术研究所
  • 合约研究组织（CRO）
  • 其他最终用户
  • 全球胜任细胞市场：细菌胜任细胞类型、效能及预测（2019-2024、2024-2029、2034）
  • 大肠桿菌胜任细胞
  • 沙门氏菌胜任细胞
  • 梭菌胜任细胞
  • 芽孢桿菌胜任细胞
  • 全球胜任细胞市场：酵母胜任细胞类型、效能及预测（2019-2024、2024-2029、2034）
  • 酿酒酵母胜任细胞
  • 毕赤酵母胜任细胞
  • 裂殖酵母胜任细胞
  • 全球胜任细胞市场：植物胜任细胞类型、效能及预测（2019-2024、2024-2029、2034）
  • 拟南芥电胜任细胞
  • 本氏烟胜任细胞
  • 玉米胜任细胞
  • 全球胜任细胞市场：哺乳动物胜任细胞类型、表现及预测（2019-2024、2024-2029、2034）
  • HEK293胜任细胞
  • 中国仓鼠卵巢（CHO）胜任细胞
  • NIH 3T3胜任细胞

第七章 区域和国家分析

  • 全球胜任细胞市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球胜任细胞市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 电转化胜任细胞市场：竞争格局
  • 电转化胜任细胞市场：公司简介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Lonza Biosciences Overview, Products and Services, Strategy and Financial Analysis
    • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Takara Bio Inc.
  • Promega Corporation
  • New England Biolabs
  • OriGene Technologies
  • MaxCyte
  • LGC Biosearch Technologies
  • IBA GmbH
  • Zymo Research
  • Creative Biolabs
  • Inovio Pharmaceuticals Inc.
  • Canvax
  • Yeastern Biotech
  • ZellBio GmbH
  • Scarab Genomics LLC
  • Intact Genomics

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年胜任细胞市场：提供新机会的国家
  • 2029年胜任细胞市场：细分领域带来新机会
  • 2029年电转化胜任细胞市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r35405

Electrocompetent cells are bacterial cells specially prepared to enhance their capacity to absorb foreign deoxyribonucleic acid (DNA) through electroporation. Their membranes become permeable through a washing procedure using a cold, ion-free solution, typically containing glycerol or water. Upon exposure to a brief electric pulse, membrane pores open, permitting plasmid DNA to enter. These cells are widely used when high transformation efficiency is crucial in genetic engineering.

The primary product categories of electrocompetent cells include bacterial electrocompetent cells, yeast electrocompetent cells, plant electrocompetent cells, and mammalian electrocompetent cells. Bacterial electrocompetent cells are designed with permeable membranes to facilitate efficient DNA uptake during electroporation. These cells use various technologies such as electroporation, chemical transformation, and others, and are offered in multiple packaging formats including tubes, plates, and customized options. Their applications span gene cloning, protein expression, transfection studies, gene editing, therapeutic research, and more. They are utilized by a range of end users, including pharmaceutical and biotechnology firms, academic and research institutions, contract research organizations (CROs), and others.

The electrocompetent cells market research report is one of a series of new reports from The Business Research Company that provides electrocompetent cells market statistics, including the electrocompetent cells industry global market size, regional shares, competitors with the electrocompetent cells market share, detailed electrocompetent cells market segments, market trends, opportunities, and any further data you may need to thrive in the electrocompetent cells industry. This electrocompetent cells market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The electrocompetent cells market size has grown rapidly in recent years. It will grow from $1.43 billion in 2024 to $1.58 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth observed during the historic period can be attributed to the increasing demand for recombinant protein production, a rise in academic and government research funding, the expansion of molecular biology research, the adoption of gene cloning methods, and the availability of high-efficiency E. coli strains.

The electrocompetent cells market size is expected to see rapid growth in the next few years. It will grow to $2.31 billion in 2029 at a compound annual growth rate (CAGR) of 10.0%. The projected growth in the forecast period is driven by expanding applications in synthetic biology, rising demand for CRISPR-based gene editing, the growth of personalized medicine research, the emergence of automation in transformation procedures, and increased investments from biotech startups. Key trends anticipated during this period include CRISPR-compatible electrocompetent cells, high-efficiency transformation strains, integration of chemically defined growth media, automated cell preparation processes, and cold-chain optimized packaging to ensure product stability.

The growing demand for genetic engineering is expected to drive the expansion of the electrocompetent cells market. Genetic engineering involves the deliberate alteration of an organism's DNA to change its characteristics or functions. This demand is largely fueled by the need to boost agricultural productivity through the development of high-yield, pest-resistant crops, which reduce dependence on chemical inputs. As genetic engineering becomes more integral across agriculture, healthcare, and research, the need for high-quality electrocompetent cells-used to efficiently introduce foreign DNA into cells-is also increasing. For example, in April 2025, the Economic Research Service, a U.S. government agency, reported that in 2024, genetically engineered insect-resistant seeds were planted on 90% of cotton acreage in the U.S. As such, the rising use of genetic engineering is contributing to the growth of the electrocompetent cells market.

Leading companies in the electrocompetent cells market are focusing on innovations such as automated cell processing technologies to support the scalability of genetic engineering applications. These automated systems manage tasks such as cell handling, cultivation, modification, and preservation using software-driven protocols, which enhance efficiency, consistency, and scalability-especially in fields such as cell therapy, regenerative medicine, and biomanufacturing. For instance, in March 2022, Thermo Fisher Scientific Inc., a U.S.-based biotechnology firm, introduced the Gibco CTS Xenon electroporation system. This large-volume, customizable electroporation platform is designed for rapid, non-viral gene modification and enables seamless transition from clinical to commercial-scale production. It offers programmable conditions, maintains high cell viability (up to 80%), and delivers efficient gene knockout (up to 90%) for hard-to-transfect cells within a sterile, closed system.

In January 2024, MaxCyte Inc., a U.S.-based provider of electroporation systems, formed a partnership with Wugen Inc. to enhance scalable cell engineering technologies for cancer treatment. The collaboration aims to accelerate the clinical and commercial manufacturing of Wugen's allogeneic, off-the-shelf cell therapies, which are designed to treat both hematologic and solid tumor cancers. By leveraging MaxCyte's efficient, scalable cell engineering technology, the partnership seeks to advance therapeutic options for patients with limited treatments available. Wugen Inc. is a U.S.-based company specializing in cellular therapies for cancer.

Major players in the electrocompetent cells market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Lonza Biosciences, Bio-Rad Laboratories Inc., Takara Bio Inc., Promega Corporation, New England Biolabs, OriGene Technologies, MaxCyte, LGC Biosearch Technologies, IBA GmbH, Zymo Research, Creative Biolabs, Inovio Pharmaceuticals Inc., Canvax, Yeastern Biotech, ZellBio GmbH, Scarab Genomics LLC, and Intact Genomics.

North America was the largest region in the electrocompetent cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in electrocompetent cells report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the electrocompetent cells market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The electrocompetent cells market consists of revenues earned by entities by providing services such as custom strain development, plasmid DNA amplification, library construction, and technical support for molecular biology applications. The market value includes the value of related goods sold by the service provider or included within the service offering. The electrocompetent cells market includes sales of insect electrocompetent cells, fungal electrocompetent cells, and algal electrocompetent cells. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Electrocompetent Cells Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on electrocompetent cells market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for electrocompetent cells ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The electrocompetent cells market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Bacterial Electrocompetent Cells; Yeast Electrocompetent Cells; Plant Electrocompetent Cells; Mammalian Electrocompetent Cells
  • 2) By Technology: Electroporation Technology; Chemical Transformation Technology; Other Technologies
  • 3) By Packaging Format: Tubes; Plates; Custom Formats
  • 4) By Application: Gene Cloning; Protein Expression; Transfection Studies; Gene Editing; Therapeutic Applications; Other Applications
  • 5) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organizations (CROs); Other End-Users
  • Subsegments:
  • 1) By Bacterial Electrocompetent Cells: E. coli Electrocompetent Cells; Salmonella Electrocompetent Cells; Clostridium Electrocompetent Cells; Bacillus Electrocompetent Cells
  • 2) By Yeast Electrocompetent Cells: Saccharomyces Cerevisiae Electrocompetent Cells; Pichia Pastoris Electrocompetent Cells; Schizosaccharomyces Pombe Electrocompetent Cells
  • 3) By Plant Electrocompetent Cells: Arabidopsis Thaliana Electrocompetent Cells; Nicotiana Benthamiana Electrocompetent Cells; Maize Electrocompetent Cells
  • 4) By Mammalian Electrocompetent Cells: HEK293 Electrocompetent Cells; Chinese Hamster Ovary (CHO) Electrocompetent Cells; NIH 3T3 Electrocompetent Cells
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Agilent Technologies Inc.; Lonza Biosciences; Bio-Rad Laboratories Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Electrocompetent Cells Market Characteristics

3. Electrocompetent Cells Market Trends And Strategies

4. Electrocompetent Cells Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Electrocompetent Cells Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Electrocompetent Cells PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Electrocompetent Cells Market Growth Rate Analysis
  • 5.4. Global Electrocompetent Cells Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Electrocompetent Cells Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Electrocompetent Cells Total Addressable Market (TAM)

6. Electrocompetent Cells Market Segmentation

  • 6.1. Global Electrocompetent Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bacterial Electrocompetent Cells
  • Yeast Electrocompetent Cells
  • Plant Electrocompetent Cells
  • Mammalian Electrocompetent Cells
  • 6.2. Global Electrocompetent Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electroporation Technology
  • Chemical Transformation Technology
  • Other Technologies
  • 6.3. Global Electrocompetent Cells Market, Segmentation By Packaging Format, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tubes
  • Plates
  • Custom Formats
  • 6.4. Global Electrocompetent Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gene Cloning
  • Protein Expression
  • Transfection Studies
  • Gene Editing
  • Therapeutic Applications
  • Other Applications
  • 6.5. Global Electrocompetent Cells Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Academic And Research Institutes
  • Contract Research Organizations (CROs)
  • Other End-Users
  • 6.6. Global Electrocompetent Cells Market, Sub-Segmentation Of Bacterial Electrocompetent Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • E. coli Electrocompetent Cells
  • Salmonella Electrocompetent Cells
  • Clostridium Electrocompetent Cells
  • Bacillus Electrocompetent Cells
  • 6.7. Global Electrocompetent Cells Market, Sub-Segmentation Of Yeast Electrocompetent Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Saccharomyces Cerevisiae Electrocompetent Cells
  • Pichia Pastoris Electrocompetent Cells
  • Schizosaccharomyces Pombe Electrocompetent Cells
  • 6.8. Global Electrocompetent Cells Market, Sub-Segmentation Of Plant Electrocompetent Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Arabidopsis Thaliana Electrocompetent Cells
  • Nicotiana Benthamiana Electrocompetent Cells
  • Maize Electrocompetent Cells
  • 6.9. Global Electrocompetent Cells Market, Sub-Segmentation Of Mammalian Electrocompetent Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • HEK293 Electrocompetent Cells
  • Chinese Hamster Ovary (CHO) Electrocompetent Cells
  • NIH 3T3 Electrocompetent Cells

7. Electrocompetent Cells Market Regional And Country Analysis

  • 7.1. Global Electrocompetent Cells Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Electrocompetent Cells Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Electrocompetent Cells Market

  • 8.1. Asia-Pacific Electrocompetent Cells Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Electrocompetent Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Electrocompetent Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Electrocompetent Cells Market, Segmentation By Packaging Format, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Electrocompetent Cells Market

  • 9.1. China Electrocompetent Cells Market Overview
  • 9.2. China Electrocompetent Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Electrocompetent Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Electrocompetent Cells Market, Segmentation By Packaging Format, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Electrocompetent Cells Market

  • 10.1. India Electrocompetent Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Electrocompetent Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Electrocompetent Cells Market, Segmentation By Packaging Format, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Electrocompetent Cells Market

  • 11.1. Japan Electrocompetent Cells Market Overview
  • 11.2. Japan Electrocompetent Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Electrocompetent Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Electrocompetent Cells Market, Segmentation By Packaging Format, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Electrocompetent Cells Market

  • 12.1. Australia Electrocompetent Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Electrocompetent Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Electrocompetent Cells Market, Segmentation By Packaging Format, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Electrocompetent Cells Market

  • 13.1. Indonesia Electrocompetent Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Electrocompetent Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Electrocompetent Cells Market, Segmentation By Packaging Format, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Electrocompetent Cells Market

  • 14.1. South Korea Electrocompetent Cells Market Overview
  • 14.2. South Korea Electrocompetent Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Electrocompetent Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Electrocompetent Cells Market, Segmentation By Packaging Format, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Electrocompetent Cells Market

  • 15.1. Western Europe Electrocompetent Cells Market Overview
  • 15.2. Western Europe Electrocompetent Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Electrocompetent Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Electrocompetent Cells Market, Segmentation By Packaging Format, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Electrocompetent Cells Market

  • 16.1. UK Electrocompetent Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Electrocompetent Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Electrocompetent Cells Market, Segmentation By Packaging Format, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Electrocompetent Cells Market

  • 17.1. Germany Electrocompetent Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Electrocompetent Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Electrocompetent Cells Market, Segmentation By Packaging Format, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Electrocompetent Cells Market

  • 18.1. France Electrocompetent Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Electrocompetent Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Electrocompetent Cells Market, Segmentation By Packaging Format, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Electrocompetent Cells Market

  • 19.1. Italy Electrocompetent Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Electrocompetent Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Electrocompetent Cells Market, Segmentation By Packaging Format, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Electrocompetent Cells Market

  • 20.1. Spain Electrocompetent Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Electrocompetent Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Electrocompetent Cells Market, Segmentation By Packaging Format, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Electrocompetent Cells Market

  • 21.1. Eastern Europe Electrocompetent Cells Market Overview
  • 21.2. Eastern Europe Electrocompetent Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Electrocompetent Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Electrocompetent Cells Market, Segmentation By Packaging Format, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Electrocompetent Cells Market

  • 22.1. Russia Electrocompetent Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Electrocompetent Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Electrocompetent Cells Market, Segmentation By Packaging Format, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Electrocompetent Cells Market

  • 23.1. North America Electrocompetent Cells Market Overview
  • 23.2. North America Electrocompetent Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Electrocompetent Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Electrocompetent Cells Market, Segmentation By Packaging Format, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Electrocompetent Cells Market

  • 24.1. USA Electrocompetent Cells Market Overview
  • 24.2. USA Electrocompetent Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Electrocompetent Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Electrocompetent Cells Market, Segmentation By Packaging Format, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Electrocompetent Cells Market

  • 25.1. Canada Electrocompetent Cells Market Overview
  • 25.2. Canada Electrocompetent Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Electrocompetent Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Electrocompetent Cells Market, Segmentation By Packaging Format, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Electrocompetent Cells Market

  • 26.1. South America Electrocompetent Cells Market Overview
  • 26.2. South America Electrocompetent Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Electrocompetent Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Electrocompetent Cells Market, Segmentation By Packaging Format, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Electrocompetent Cells Market

  • 27.1. Brazil Electrocompetent Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Electrocompetent Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Electrocompetent Cells Market, Segmentation By Packaging Format, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Electrocompetent Cells Market

  • 28.1. Middle East Electrocompetent Cells Market Overview
  • 28.2. Middle East Electrocompetent Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Electrocompetent Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Electrocompetent Cells Market, Segmentation By Packaging Format, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Electrocompetent Cells Market

  • 29.1. Africa Electrocompetent Cells Market Overview
  • 29.2. Africa Electrocompetent Cells Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Electrocompetent Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Electrocompetent Cells Market, Segmentation By Packaging Format, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Electrocompetent Cells Market Competitive Landscape And Company Profiles

  • 30.1. Electrocompetent Cells Market Competitive Landscape
  • 30.2. Electrocompetent Cells Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Lonza Biosciences Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Electrocompetent Cells Market Other Major And Innovative Companies

  • 31.1. Takara Bio Inc.
  • 31.2. Promega Corporation
  • 31.3. New England Biolabs
  • 31.4. OriGene Technologies
  • 31.5. MaxCyte
  • 31.6. LGC Biosearch Technologies
  • 31.7. IBA GmbH
  • 31.8. Zymo Research
  • 31.9. Creative Biolabs
  • 31.10. Inovio Pharmaceuticals Inc.
  • 31.11. Canvax
  • 31.12. Yeastern Biotech
  • 31.13. ZellBio GmbH
  • 31.14. Scarab Genomics LLC
  • 31.15. Intact Genomics

32. Global Electrocompetent Cells Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Electrocompetent Cells Market

34. Recent Developments In The Electrocompetent Cells Market

35. Electrocompetent Cells Market High Potential Countries, Segments and Strategies

  • 35.1 Electrocompetent Cells Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Electrocompetent Cells Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Electrocompetent Cells Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer